Sam Altman-Backed Startup Uses AI to Accelerate Drug Clinical Trials

A $1.8 billion startup, backed by Sam Altman, is leveraging artificial intelligence to significantly speed up the process of getting drugs through clinical trials.

17 Apr, 10:30 — 17 Apr, 10:30

Post Share

Sources

Showing 1 of 1 sources

forbes2d ago

This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster - Forbes

This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster Forbes

Read full article →

PERSPECTA

PERSPECTA

Sam Altman-Backed Startup Uses AI to Accelerate Drug Clinical Trials

Sources

This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster - Forbes

Related Stories

Cavite Forecasts 'Dangerous' 42°C Heat Index

MP Brittas Seeks Intervention on Student Suicides at NIT Kurukshetra

Jūra Smilgaitė. US drug policy changes threaten to leave Europe without the latest treatments

UGC Flags Institutional Failures in Dharamshala Student Suicide Case

PERSPECTA